Austrian Research Promotion Agency (FFG) logo
Austrian Research Promotion Agency (FFG)

FFG Austrian Life Sciences

Supports Austrian life-science innovation in digital health, drug development, and medical technologies.

The Austrian Life Sciences 2024–2026 call funds Austrian company-led R&D and clinical studies in life sciences. Eligible focus areas are digitalization with health aspects (diagnostics, telemedicine, medical devices), new drugs and medical devices, and interventional phase I and II clinical studies. Participation along the entire value chain is required; foreign partners may participate depending …

Digitalization with health aspects; new drugs and medical devices; planning and implementation of interventional phase I and II clinical studies.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.€45M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Guides for this application

All guides →
European Commission logo
Scheduled

Young Cancer Survivors Quality of Life Network

🇪🇺European Commission · European Union

Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.

MedtechBiotech+1
€3MSep'27
Innovative Health Initiative Joint Undertaking (IHI JU) logo
Open

Decode the Immunoscience of age-related diseases

🇪🇺IHI JU · European Union

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

BiotechMedtech
€9.2MOct'26
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27
FWF (Austrian Science Fund) logo
Open

FWF ASTRA Awards — Next

🇦🇹FWF · Austria

Supports Austrian postdoctoral excellence through advanced awards for innovative research in science and engineering.

BiotechMedtech+6
€500K – €1M
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

🇪🇺European Commission · European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
€6M – €8MApr'27
European Commission logo
Scheduled

Towards Artificial General Intelligence (AGI) for healthcare

🇪🇺European Commission · European Union

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

AIBiotech+1
€2.9MSep'27